Want to see IMVT full AI Analyst Report?

Immunovant (IMVT) Revenue

964 Followers

Immunovant Revenue

Immunovant had a revenue of 7.09M in the quarter ending Jun 30, 2026, with Infinity%. This bring the company's revenue in the last twelve months to 7.09M, Decreased Infinity%. In the fiscal year ending Mar 31, 2026, Immunovant had annual revenue of 0.00 with ― growth.

Revenue (ttm)

7.09M

Revenue Growth

―

P/S Ratio

―

Revenue/Employee

Employees

315

Market Cap

$8.00B

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Mar 31, 2026	―	―	―
Mar 31, 2025	―	―	―
Mar 31, 2024	―	―	―
Mar 31, 2023	―	―	―
Mar 31, 2022	―	―	―
Mar 31, 2021	―	―	―
Mar 31, 2020	―	―	―
Mar 31, 2019	―	―	―
Mar 31, 2018	―	―	―